About BBM
Science & Pipeline
News Center
IR Contact
Careers
Belief BioMed Co-Founder and CEO Dr. Jane Zheng was selected by Forbes as one of the "50 Chinese Women in Science and Technology"!
KPMG China Biotechnology Innovation 50 List and Future Healthcare 100 Value Area List
Clinical results for Belief BioMed’s developing hemophilia B gene treatment BBM-H901 published in authoritative hematology journal The Lancet Haematology
The launch of the 14th five-year National Key Research and Development program "Research and Development of Gene Therapy products for Fatal Birth Defects and Clinical Research" was held successfully
Belief BioMed Completed Dosing of the First Subject in the Registrational Gene Therapy Clinical Trial for Hemophilia B
Remarkable success once more! Belief BioMed won the award of "the 10th China Innovation and Entrepreneurship Competition Excellent Enterprise"
2021 Future Medical Industry Summit, Dr. Xiao xiao【Gene Therapy: Expansion from Rare Disease to Common Medicine】
Belief Biomed’s Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China
Belief BioMed and China Chord Rare Disease Center held a meeting in Minhang, Shanghai
Belief BioMed announced the opening of new development & manufacturing center in Minhang Shanghai
Belief BioMed seized the new developing opportunity of Lin-gang and signed a contract to construct the key project in Lin-gang Biotechnology Industrial Park
The 8th China Rare Disease Summit
Belief BioMed Invests Over 100 million RMB to Construct a State-Of-The-Art Gene Therapy Manufacturing plant in Minhang Shanghai.